WORCESTER, Mass., Sept. 8, 2011 (GLOBE NEWSWIRE) -- RXi Pharmaceuticals Corporation (Nasdaq:RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, today announced that Mark J. Ahn, President and CEO, will present a corporate overview at the 13th Annual Rodman & Renshaw Healthcare conference. The presentation will take place on Monday, September 12, 2011 at 4:30 pm EDT at the Waldorf Astoria Hotel in New York, NY.
